Skip to content
Ask Dr. Calapai
The Stem Cell Foundation
  • Home
  • About Us
  • Videos
  • Articles
  • Donate
  • Contact Us
  • Toggle website search
Menu Close
  • Home
  • About Us
  • Videos
  • Articles
  • Donate
  • Contact Us
  • Toggle website search

Monthly Archives: February 2009

  1. Home>
  2. 2009>
  3. February

EDTA CHELATION THERAPY, EFFICACY IN ARTERIOSCLEROTIC HEART DISEASE

  • Post author:2by2host
  • Post published:February 13, 2009
  • Post category:Articles/Metals

ABSTRACT: Eighteen patients with documented arteriosclerotic heart disease were studied utilizing the isotope Technetium 99m to measure left ventricular ejection fraction before and after the administration of EDTA chelation therapy.…

Continue ReadingEDTA CHELATION THERAPY, EFFICACY IN ARTERIOSCLEROTIC HEART DISEASE

Benefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospective Study of 470 Patients

  • Post author:2by2host
  • Post published:February 13, 2009
  • Post category:Articles

ABSTRACT: In a retrospective study we report results of EDTA chelation in 470 patients, using a number of parameters, most of them objective. Although the patients acted as their own…

Continue ReadingBenefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospective Study of 470 Patients

Blood lead levels in children

  • Post author:2by2host
  • Post published:February 12, 2009
  • Post category:News

Lead has been a major health risk for centuries, in all populations and all ages. It has been especially damaging to children and brain function. The typical assessment of any…

Continue ReadingBlood lead levels in children

Recent Posts

  • Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party
  • Update on mesenchymal stem cell-based therapy in lupus and scleroderma
  • Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
  • Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type
  • The safety of bone-marrow derived mesenchymal stem cells in patients with type 2 diabetes mellitus

Follow Us

Copyright 2025